美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

三倍做多標普生物-Direxion

261.30

-4.7000-1.77%

盤後：261.300.00000.00%19:58 EDT

成交量：22.74萬

成交額：6,097.03萬

市值：4.90億

市盈率：- -

高：278.96

開：273.29

低：261.30

收：266.00

52周最高：341.93

52周最低：74.95

股本：187.45萬

流通股本：187.45萬

量比：0.94

換手率：12.13%

股息：1.00

股息率：0.38%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

北汽副總史志山年薪75.41萬元連續兩年低於同期上任的副總胡漢軍

运营商财经网

傳童牧知擬加盟瑞銀出任集團亞洲醫療保健投行業務主席

醫療保健板塊動態：市場快訊匯總

醫療板塊動態：市場快訊匯總

海西新藥(02637)：HX9428用於治療新生血管性年齡相關性黃斑變性獲美國FDA授予快速通道資格

海西新藥：HX9428獲美國FDA快速通道資格用於治療nAMD

瑞銀據悉延攬高盛前老將將負責亞洲醫療保健投行業務

醫藥基金淨值大幅攀升機構配置尚處歷史低位

美國南部近160萬打雞蛋因沙門氏菌緊急召回，FDA升級最高風險警報

环球市场播报

槍殺美國聯合健康保險CEO的曼吉奧內就聯邦指控認罪

路易吉，正式認罪！他此前當街槍殺美國聯合健康保險CEO，或面臨終身監禁

每日经济新闻

路易吉，正式認罪！他此前當街槍殺美國聯合健康保險CEO，或面臨終身監禁

每日经济新闻

路易吉・曼喬內在法庭上承認，他槍擊了聯合健康保險原首席執行官布萊恩・湯普森。

施貴寶iberdomide獲FDA批准用於治療多發性骨髓瘤

惠譽：隨着醫療保險和社會保障支出到 2032 年將接近增加 1 個百分點的國內生產總值，財政壓力將會加劇。

醫療保健板塊快訊：市場動態綜述

國產胰島素製劑首登美國，這座縣城的集採藥產線優勢在哪兒

亞虹醫藥：APL-2501獲FDA批准開展晚期實體瘤臨床試驗

醫療保健板塊綜述：市場快訊

皓元醫藥(688131.SH)子公司藥源啓東通過美國FDA審計

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/LABU/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多標普生物-Direxion","latestPrice":261.3,"timestamp":1789156800000,"preClose":266,"halted":0,"volume":227375,"hourTrading":{"tag":"盘后","latestPrice":261.3,"preClose":261.3,"latestTime":"19:58 EDT","volume":728,"amount":191085.6107,"timestamp":1789171090575,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.017669172932330786,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"休市中","change":-4.7,"latestTime":"09-11 16:00:00 EDT","open":273.29,"high":278.9613,"low":261.3,"amount":60970299.293749996,"amplitude":0.066396,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":266,"sharesOutstanding":3074486,"nav":261.603,"aum":516531253.77,"dividendRate":0.003844,"bidAskSpread":0.003144,"preHourTrading":{"tag":"盘前","latestPrice":274.69,"preClose":266,"latestTime":"09:28 EDT","volume":2486,"amount":673283.80262,"timestamp":1789133308224,"change":8.69,"changeRate":0.032669,"amplitude":0.031541},"postHourTrading":{"tag":"盘后","latestPrice":261.3,"preClose":261.3,"latestTime":"19:58 EDT","volume":728,"amount":191085.6107,"timestamp":1789171090575,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9397711565267511,"impliedVol":0.8728,"impliedVolPercentile":0.3227},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9397711565267511,"shares":1874486,"dividePrice":1.0045,"high":278.9613,"amplitude":0.066396,"preClose":266,"low":261.3,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":261.3,"eps":0,"divideRate":0.003844,"volume":227375,"delay":0,"ttmEps":0,"open":273.29,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":305.86,"twentyDayClose":273.91,"sixtyDayClose":184.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660468932","title":"北汽副總史志山年薪75.41萬元 連續兩年低於同期上任的副總胡漢軍","url":"https://stock-news.laohu8.com/highlight/detail?id=2660468932","media":"运营商财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660468932?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 16:08","pubTimestamp":1787040480,"startTime":"0","endTime":"0","summary":"运营商财经网 汽车频道王鑫垚/文近日，北汽集团公开高管2024年薪酬情况。数据显示，胡汉军在2024年拿到薪酬77.2万元，此外还有19.67万元的社会保险、企业年金、补充医疗保险及住房公积金的单位缴存部分。两方面合计达到96.87万元；史志山2024年薪酬为75.41万元，比胡汉军低了1.79万元。据了解，胡汉军和史志山都是在2023年上任北汽集团副总经理一职。当年，史志山的税前薪酬和综合隐性福利都不如胡汉军。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-18/doc-inintpin8658136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","XBI","BK4581","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660683452","title":"傳童牧知擬加盟瑞銀 出任集團亞洲醫療保健投行業務主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2660683452","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660683452?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 14:08","pubTimestamp":1787033333,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据媒体引述知情人士透露，已从高盛离职的资深投行家童牧知(Samuel Thong)，拟于10月加入瑞银集团、出任瑞银亚洲医疗保健投资银行业务主席一职。资料显示，童牧知博士在医疗保健投资银行领域深耕多年，是一位资深的医疗保健投行家，从业时间约30年，拥有芝加哥大学医学博士、MBA学位。2019年，他从摩根士丹利跳槽至高盛，出任高盛投资银行部亚洲(除日本)医疗保健团队主席，并兼任该团队联席主管。于今年早些时候，他从高盛离职。在加入摩根士丹利负责亚洲医疗保健投行业务之前，他曾任职于美银美林。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XLFI","KNAB","BK4581","BK4588","BK4585","IEFN","XLV","BK4550","BNKZ","IAI","NOBL","BK4582","BNKO","BCFN","VHT","FAS","CGVV","JHMF","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176123870","title":"醫療保健板塊動態：市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1176123870","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176123870?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 04:54","pubTimestamp":1787000078,"startTime":"0","endTime":"0","summary":"涵盖医疗保健领域的最新市场快讯，于美国东部时间4:20、12:20及16:50在道琼斯通讯社独家发布。根据协议，两家公司将携手推进多达十种生物类似药的开发与商业化，商业化相关付款总额最高可达3.22亿美元。塞夫顿表示，此项协议\"彰显了山德士在生物类似药商业化合作领域的领先地位\"。该药物占阿斯利康为其设定的超过50亿美元销售目标的约20%。该公司股价下跌1.2%，报0.83新加坡元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4588","BK4585","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169996683","title":"醫療板塊動態：市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1169996683","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169996683?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 00:26","pubTimestamp":1786983993,"startTime":"0","endTime":"0","summary":"医疗健康领域最新市场快讯，涵盖制药巨头动态与行业投资风向。根据协议，双方将共同推进多达十种生物类似药的开发与商业化，商业化相关付款总额最高可达3.22亿美元。消息公布后，山德士股价上涨3.15%，报75.3瑞士法郎。0620 GMT——摩根大通分析师认为，阿斯利康终止一项肺癌药物试验虽令人失望，但其他药物的积极数据可能推动市场对其销售指引预期上调。该股下跌1.2%，报0.83新加坡元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XLV","BK4588","BK4585","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482197","title":"海西新藥(02637)：HX9428用於治療新生血管性年齡相關性黃斑變性獲美國FDA授予快速通道資格","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482197","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660482197?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 19:50","pubTimestamp":1786967418,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海西新药 发布公告，公司自主研发的创新药项目HXP056的候选药物分子HX9428，获美国食品药品监督管理局授予快速通道资格，用于开发治疗新生血管性年龄相关性黄斑变性。HX9428是海西新药自主研发的全新口服小分子创新药物，拟用于治疗nAMD。海外研发同步落地，HX9428已获FDA批准在美国开展nAMD适应症II期临床试验，公司正全力推进美国临床开发布局，以期早日惠及全球患者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1191","02637","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482920","title":"海西新藥：HX9428獲美國FDA快速通道資格用於治療nAMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482920","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660482920?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 19:48","pubTimestamp":1786967309,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660101918","title":"瑞銀據悉延攬高盛前老將 將負責亞洲醫療保健投行業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2660101918","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660101918?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 11:24","pubTimestamp":1786937087,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0061475181.USD","LU2750360997.AUD","IE00B19Z3B42.SGD","LU2471134879.HKD","LU1791807156.HKD","LABU","VHT","LU1804176565.USD","LU2237443465.HKD","BK4550","LU1868837136.USD","NOBL","JHMF","LU0048573561.USD","LU0868494708.USD","LU0106831901.USD","BK4552","BCFN","LU1668664300.SGD","FAS","IE0002270589.USD","LU2237443622.USD","LU2237443978.SGD","IAI","LU1894683264.USD","LU0942090050.USD","GS","LU2750360641.GBP","BK4516","GSX","LU1868836757.USD","IE00B19Z3581.USD","LU2237443895.HKD","BNKZ","IEFN","IE0004086264.USD","LU0251142724.SGD","XLFI","LU2471134952.CNY","BK4582","CGVV","BK4127","KNAB","XLV","XBI","LU2237443382.USD","LU2237443549.SGD","BNKO","BK4588","LU2471134796.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660108069","title":"醫藥基金淨值大幅攀升 機構配置尚處歷史低位","url":"https://stock-news.laohu8.com/highlight/detail?id=2660108069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660108069?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 06:17","pubTimestamp":1786918664,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4550","LABU","XBI","VHT","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659174853","title":"美國南部近160萬打雞蛋因沙門氏菌緊急召回，FDA升級最高風險警報","url":"https://stock-news.laohu8.com/highlight/detail?id=2659174853","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659174853?lang=zh_tw&edition=fundamental","pubTime":"2026-08-16 14:35","pubTimestamp":1786862100,"startTime":"0","endTime":"0","summary":"国食品药品监督管理局将一起涉及近160万打鸡蛋的召回事件上调至最高风险等级，原因是相关鸡蛋可能受沙门氏菌污染。疫情规模与影响截至7月24日，与这批召回鸡蛋相关的沙门氏菌疫情已在17个州导致至少98人感染，其中26人住院。FDA执法报告中列出了具体产品信息。与生菜相关的环孢子虫病确诊病例已超过1.3万例；另有一起涉及墨西哥胡椒的沙门氏菌疫情，促使Taylor Farms产品在26个州被召回。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-16/doc-ininnuvs9842673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659131127","title":"槍殺美國聯合健康保險CEO的曼吉奧內就聯邦指控認罪","url":"https://stock-news.laohu8.com/highlight/detail?id=2659131127","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659131127?lang=zh_tw&edition=fundamental","pubTime":"2026-08-15 09:50","pubTimestamp":1786758600,"startTime":"0","endTime":"0","summary":"据CCTV国际时讯消息，8月14日，被控枪杀美国联合健康保险公司首席执行官布赖恩·汤普森（BrianThompson）的路易吉·曼吉奥内在法庭上表示，他就其联邦刑事案件认罪，承认自己枪杀了汤普森。这一认罪协议将避免这起备受瞩目的案件进入联邦审判阶段。此外，认罪还可能使曼吉奥内得以寻求撤销纽约州的谋杀指控，并推迟即将到来的州审判。曼吉奥内目前面临联邦指控和州指控。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608153842363652.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608153842363652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XBI","BK4588","BK4581","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659552127","title":"路易吉，正式認罪！他此前當街槍殺美國聯合健康保險CEO，或面臨終身監禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2659552127","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659552127?lang=zh_tw&edition=fundamental","pubTime":"2026-08-15 08:22","pubTimestamp":1786753353,"startTime":"0","endTime":"0","summary":"当地时间8月14日，路易吉·曼吉奥内就枪杀联合健康保险首席执行官布赖恩·汤普森（BrianThompson）一案正式认罪。联邦法官将路易吉·曼吉奥内的量刑日期定于12月18日。路易吉·曼吉奥内当天在法庭上表示，他就其联邦刑事案件认罪，承认自己枪杀了汤普森。这一认罪协议将避免这起备受瞩目的案件进入联邦审判阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608153842343196.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608153842343196.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XBI","BK4588","BK4581","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659276311","title":"路易吉，正式認罪！他此前當街槍殺美國聯合健康保險CEO，或面臨終身監禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2659276311","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659276311?lang=zh_tw&edition=fundamental","pubTime":"2026-08-15 08:22","pubTimestamp":1786753320,"startTime":"0","endTime":"0","summary":"路易吉·曼吉奥内当天在法庭上表示，他就其联邦刑事案件认罪，承认自己枪杀了汤普森。此外，认罪还可能使曼吉奥内得以寻求撤销纽约州的谋杀指控，并推迟即将到来的州审判。曼吉奥内目前面临联邦指控和州指控。州级指控方面，曼吉奥内此前面临二级谋杀、非法持有武器、持有虚假身份证明等多项罪名指控。如果二级谋杀罪名成立，曼吉奥内将面临25年至终身监禁的刑罚。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-08-15/doc-ininiyys3677355.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-15/doc-ininiyys3677355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4588","LABU","BK4581","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659128599","title":"路易吉・曼喬內在法庭上承認，他槍擊了聯合健康保險原首席執行官布萊恩・湯普森。","url":"https://stock-news.laohu8.com/highlight/detail?id=2659128599","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659128599?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 23:40","pubTimestamp":1786722026,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4581","XBI","XLV","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659219498","title":"施貴寶iberdomide獲FDA批准用於治療多發性骨髓瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2659219498","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659219498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 10:28","pubTimestamp":1786674495,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BMY","LU2125154935.USD","LU0868494617.USD","IE0002141913.USD","LU2133065610.SGD","IE0009355771.USD","BK4559","IE00BFXG1179.USD","LU1718418525.SGD","LU1983299246.USD","LABU","LU0096364046.USD","LU0882574055.USD","LU0432979614.USD","LU1670710661.SGD","LU1093756168.USD","LU0306806265.USD","LU2360032135.SGD","LU1261432733.SGD","LU1868836757.USD","LU2242652126.USD","IE00BJT1NW94.SGD","LU0237698245.USD","FTXH","LU1989771016.USD","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","BK4534","IHE","LU1093756325.SGD","BK4581","LU0306807586.USD","LU0267386448.USD","LU0061475181.USD","IE00B2B36J28.USD","LU0321505868.SGD","LU1670710588.SGD","LU0225771236.USD","LU0225284248.USD","IE00BFTCPJ56.SGD","LU2125154778.USD","LU1291159041.SGD","LU1868836591.USD","LU1430594728.SGD","BK4588","LU1032466523.USD","LU1868837136.USD","LU1323610961.USD","LU1074936037.SGD","LU1868836914.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167007","title":"惠譽： 隨着醫療保險和社會保障支出到 2032 年將接近增加 1 個百分點的國內生產總值，財政壓力將會加劇。","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167007","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167007?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 04:39","pubTimestamp":1786653589,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","XBI","BK4585","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141376784","title":"醫療保健板塊快訊：市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1141376784","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141376784?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 00:24","pubTimestamp":1786638273,"startTime":"0","endTime":"0","summary":"医疗保健行业最新市场动态速览。该报道内容精选自专题市场快讯。该协会援引内部调查数据称，从去年1月到今年6月，Interpharma的成员企业，在总共22款新药中，有7款拒绝向瑞士医保机构提交报销申请。Interpharma表示，为了不危及美国市场的定价，药企往往会搁置其研发的新药，平均每三款就有一款暂停提交申请。KPJ Healthcare第二季度核心净利润预计将环比走强。该股目前股价持平，报3.07林吉特。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4588","XLV","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659875157","title":"國產胰島素製劑首登美國，這座縣城的集採藥產線優勢在哪兒","url":"https://stock-news.laohu8.com/highlight/detail?id=2659875157","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659875157?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 20:42","pubTimestamp":1786624975,"startTime":"0","endTime":"0","summary":"胰岛素专项集采实施的第五年，国产胰岛素制剂首度叩开美国商业化大门。值得关注的是，该批行销美国的产品，产自集采中的“老面孔”——湖北县城宜都的集采药品生产专线。尽管此前尚未有国产胰岛素成品制剂拿到FDA（美国食品药品监督管理局）上市批件，但“国内集采与欧美市场双向供货、共线生产”的模式，已非孤例。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608133840704812.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608133840704812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659153765","title":"亞虹醫藥：APL-2501獲FDA批准開展晚期實體瘤臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2659153765","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659153765?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 18:31","pubTimestamp":1786617088,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BMED","IBBQ","BK4585","PSYK","IBBJ","MDTX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161156613","title":"醫療保健板塊綜述：市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1161156613","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161156613?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 16:24","pubTimestamp":1786609477,"startTime":"0","endTime":"0","summary":"以下为最新医疗保健板块市场快讯，内容涵盖亚太及北美市场动态。RHB维持对KPJ的“买入”评级，目标股价定为3.77林吉特。Apotex公司在公开市场首秀中，其美国业务部门成为明显的软肋。该丹麦制药商的CEO似乎对减肥药丸市场的前景非常乐观，但贝伦贝格认为，诺和诺德可能需要通过交易来增加更多的口服药物，以维持其领先地位。贝伦贝格将诺和诺德股票的评级从“买入”下调至“持有”，并将目标价从325丹麦克朗下调至305丹麦克朗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588","BK4581","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658976075","title":"皓元醫藥(688131.SH)子公司藥源啓東通過美國FDA審計","url":"https://stock-news.laohu8.com/highlight/detail?id=2658976075","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658976075?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 18:28","pubTimestamp":1786530504,"startTime":"0","endTime":"0","summary":"智通财经APP讯，皓元医药(688131.SH)发布公告，公司全资子公司药源生物科技(启东)有限公司(简称“药源启东”)于2026年6月22日至2026年6月26日接受了来自美国食品药品监督管理局(简称“FDA”)的药品批准前检查。近日，公司收到药源启东转发的美国FDA签发的现场检查报告，该报告表明药源启东以零缺陷通过本次现场检查。此次为公司制剂生产基地首次接受美国FDA检查并顺利通过，为公司持续拓展美国市场提供了坚实的保障。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK0216","LABU","BK4588","688131"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}